Advertisement

Dermatology in Systemic Disease

  • Herbert B. Allen
Chapter
  • 913 Downloads

Abstract

Keywords in this section refer to diseases in many different areas of internal medicine. These diseases include, among others, collagen vascular, endocrine, hematologic, gastrointestinal, and neoplastic diseases. The collagen vascular disorders include lupus erythematosus, scleroderma, and dermatomyositis. Polyarteritis nodosa has two main components: systemic and cutaneous, but has no keyword. The livedo pattern on the lower legs in cutaneous polyarteritis is very characteristic but may be seen in other disorders, including other collagen diseases. The dull red nodules on the lower legs seen in both cutaneous and systemic polyarteritis are similarly nondiagnostic.

Lupus erythematosus has two variants with keywords: systemic lupus erythematosus (SLE) with butterfly rash and discoid lupus erythematosus (DLE) with follicular plugging. Other variants such as lupus tumidus, subacute cutaneous lupus, and lupus profundus, even though clinically recognizable, have no keywords. Lupus tumidus has red, edematous plaques generally distributed over the upper trunk and extremities; on occasion it resembles what formerly was described as “reticulate erythematosus mucinosis” syndrome. Otherwise, the plaques are relatively nondescript. A biopsy and laboratory findings help clarify the diagnosis.

Keywords

Butterfly rash Follicular plugging Sclerodactyly CREST Lilac border Tryptophan Yellow plaque (on shin) Proptosis Pinch purpura Heparin Lupus anticoagulant Blue nose Palpable purpura Cayenne pepper Exclamation point hair Gottron papules heliotrope mechanic’s hands Porcelain white Bulging lacrimals Velvety plaque Pig skin Spider Casal’s necklace Dermopathy Dark scars dark creases 

References

  1. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. 2005;4:296-302. Epub 2005 Feb 10.Google Scholar
  2. .
    Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol. 2006;47:13-27.CrossRefPubMedGoogle Scholar
  3. .
    Haustein UF. Systemic sclerosis-scleroderma [review]. Dermatol Online J. 2002;8:3.PubMedGoogle Scholar
  4. .
    Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P. Localized scleroderma/morphea. Int J Dermatol. 2002;41:467-475.CrossRefPubMedGoogle Scholar
  5. Blackburn WD Jr. Eosinophilia myalgia syndrome. Semin Arthritis Rheum. 1997;26:788-793.CrossRefPubMedGoogle Scholar
  6. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol. 2005;152:581-582.CrossRefPubMedGoogle Scholar
  7. Callen J, Jorizzo J, Bolognia J, Piette W. Dermatological Signs of Internal Disease, 3rd ed. Philadelphia, PA: W.B. Saunders; 2003:176-177.Google Scholar
  8. Boyce S, Harper J. Paraneoplastic dermatoses. Dermatol Clin. 2002;20: 523-532.CrossRefPubMedGoogle Scholar
  9. Rice L, Nguyen PH, Vann AR. Preventing complications in heparin-induced thrombocytopenia: alternative anticoagulants are improving patient outcomes. Postgrad Med. 2002;112:85-89.CrossRefPubMedGoogle Scholar
  10. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 2001;80:355-377.CrossRefGoogle Scholar
  11. Fitzpatrick T, Johnson R. Color Atlas and Synopsis of Clinical Dermatology. New York, NY: McGraw-Hill; 2001.Google Scholar
  12. Ansell BM, Falcini F. Cutaneous vasculitis in children. Clin Dermatol. 1999;17:577-580.CrossRefPubMedGoogle Scholar
  13. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482-488.CrossRefPubMedGoogle Scholar
  14. Madani S, Shapiro J. Alopecia areata update [comment in J Am Acad Dermatol. 2001, 45:640-642]. J Am Acad Dermatol. 2000;42:549-566, quiz 567-570.Google Scholar
  15. Callen JP. Dermatomyositis. Lancet. 2000;355:53-57.CrossRefPubMedGoogle Scholar
  16. Boh EE, al-Smadi RM. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin. 2002;20:533-546.Google Scholar
  17. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol. 1990;23(3, Pt 1):487-489.Google Scholar
  18. García Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol. 2002;3:497-506.CrossRefPubMedGoogle Scholar
  19. Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias ­[published correction appears in J Am Acad Dermatol. 2005; 53:496]. J Am Acad Dermatol. 2005;53:1-37, quiz 38-40.Google Scholar
  20. Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol. 1997;37:523-549, quiz 549-552.Google Scholar
  21. Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol. 2004;43:1-5.CrossRefPubMedGoogle Scholar
  22. Morgan AJ, Schwartz RA. Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447-451.CrossRefPubMedGoogle Scholar
  23. Nieman LK, Chanco Turner ML. Addison’s disease. Clin Dermatol. 2006;24:276-280.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2010

Authors and Affiliations

  • Herbert B. Allen
    • 1
  1. 1.Drexel University College of MedicinePhiladelphiaUSA

Personalised recommendations